Abstract
We have evaluated baseline and I-dopa-stimulated peripheral growth hormone releasing hormone (pGHRH) secretion in 6 obese prepubertal children and in 7 age-matched controls. Baseline pGHRH levels were no different between obese (36.6±9.8 pg/ml, mean±SE) and control children (40.6±10.1 pg/ml). Administration of I-dopa (500 mg po) caused a significant increase of pGHRH levels in both the obese (65.3±19.8 pg/ml, p
| Original language | English |
|---|---|
| Pages (from-to) | 453-457 |
| Number of pages | 5 |
| Journal | Journal of Endocrinological Investigation |
| Volume | 15 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1992 |
Fingerprint
Keywords
- GH
- GHRH
- obesity
- somatostatin
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism
Cite this
Secretion of growth hormone releasing hormone in obese children. / Loche, S.; Balzano, S.; Bozzola, M.; Moretta, A.; Pintus, S.; Faedda, A.; Muntoni, A.; Carta, D.; Pintor, C.
In: Journal of Endocrinological Investigation, Vol. 15, No. 6, 1992, p. 453-457.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Secretion of growth hormone releasing hormone in obese children
AU - Loche, S.
AU - Balzano, S.
AU - Bozzola, M.
AU - Moretta, A.
AU - Pintus, S.
AU - Faedda, A.
AU - Muntoni, A.
AU - Carta, D.
AU - Pintor, C.
PY - 1992
Y1 - 1992
N2 - We have evaluated baseline and I-dopa-stimulated peripheral growth hormone releasing hormone (pGHRH) secretion in 6 obese prepubertal children and in 7 age-matched controls. Baseline pGHRH levels were no different between obese (36.6±9.8 pg/ml, mean±SE) and control children (40.6±10.1 pg/ml). Administration of I-dopa (500 mg po) caused a significant increase of pGHRH levels in both the obese (65.3±19.8 pg/ml, p
AB - We have evaluated baseline and I-dopa-stimulated peripheral growth hormone releasing hormone (pGHRH) secretion in 6 obese prepubertal children and in 7 age-matched controls. Baseline pGHRH levels were no different between obese (36.6±9.8 pg/ml, mean±SE) and control children (40.6±10.1 pg/ml). Administration of I-dopa (500 mg po) caused a significant increase of pGHRH levels in both the obese (65.3±19.8 pg/ml, p
KW - GH
KW - GHRH
KW - obesity
KW - somatostatin
UR - http://www.scopus.com/inward/record.url?scp=0026669349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026669349&partnerID=8YFLogxK
U2 - 10.1007/BF03348770
DO - 10.1007/BF03348770
M3 - Article
VL - 15
SP - 453
EP - 457
JO - Journal of Endocrinological Investigation
JF - Journal of Endocrinological Investigation
SN - 0391-4097
IS - 6
ER -